ESR1 and breast carcinoma: We have shown that the hormone, specifically L-thyroxine, T4, is a proliferative factor in vitro for breast cancer cells [6] and that, in the absence of estrogen, thyroid hormone can promote nuclear estrogen receptor-α (ERα)-dependent proliferation of breast cancer cells bearing this receptor [6].